General Announcement::J. P. Morgan Healthcare Conference San Francisco USA Presentation

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
08-Jan-2019 11:48:27
Status
New
Announcement Sub Title
J. P. Morgan Healthcare Conference San Francisco USA Presentation
Announcement Reference
SG190108OTHRWGC3
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
08/01/2019 09:17:00
Description (Please provide a detailed description of the event in the box below)
Sub: J. P. Morgan Healthcare Conference, San Francisco, USA Presentation

Dear Sir,

Kindly find enclosed herewith the presentation that will be made at the J. P. Morgan Healthcare Conference, San Francisco, USA. The same will also be made available on our website.



Attachments

PR_08012019.pdf
Total size =3668K